Centiva Capital, LP - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.

Quarter-by-quarter ownership
Centiva Capital, LP ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$538,000
-6.1%
7,700
-9.7%
0.01%
-28.6%
Q2 2022$573,000
+28.5%
8,525
+236.8%
0.01%
-50.0%
Q3 2021$446,000
-41.5%
2,531
-46.3%
0.03%
+55.6%
Q2 2021$762,000
-17.0%
4,716
-12.0%
0.02%
-48.6%
Q1 2021$918,000
-3.0%
5,357
+24.4%
0.04%
-5.4%
Q4 2020$946,000
+244.0%
4,306
+159.9%
0.04%
+105.6%
Q3 2020$275,000
-65.9%
1,657
-76.5%
0.02%
-63.3%
Q2 2020$806,0007,0590.05%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 2,881,702$14,985,0006.99%
Avoro Capital Advisors LLC 2,383,201$12,393,0001.58%
Broadfin Capital, LLC 2,090,801$10,872,0001.32%
Boxer Capital, LLC 1,037,994$5,398,0001.18%
Ghost Tree Capital, LLC 172,184$895,0000.17%
Baker Brothers Advisors 2,269,198$11,800,0000.10%
Hillhouse Capital Management 725,000$3,770,0000.07%
SABBY MANAGEMENT, LLC 249,735$1,299,0000.07%
Rhenman & Partners Asset Management AB 50,000$260,0000.04%
Trexquant Investment LP 42,879$223,0000.03%
View complete list of MIRATI THERAPEUTICS INC shareholders